Literature DB >> 20232091

Peptide heterodimers for molecular imaging.

Yongjun Yan1, Xiaoyuan Chen.   

Abstract

One main issue with peptide-based molecular imaging probes is their relatively low tumor affinity and short retention time. To improve peptide binding affinity, multivalency approach has been introduced. Traditionally, this approach involves the use of peptide homodimers or homomultimers in which peptide ligands of the same type are constructed with suitable linkers. Recently, a new approach using peptide heterodimers has emerged as a promising method for targeting multi-receptor over-expressed tumor cells. Significant affinity enhancements have been observed with peptide heterodimers compared with their parent peptide monomers. In a peptide heterodimer, two different peptide ligands capable of targeting two different receptors are covalently linked. The binding modes of peptide heterodimers can be monovalent or bivalent depending on whether simultaneous binding of two ligands can be achieved. Increased local ligand concentration and improved binding kinetics contribute to enhanced binding in both monovalent- and bivalent binding modes, while multivalency effect also plays an important role in bivalent binding mode. As many tumors overexpress multiple receptors, more peptide heterodimer-based molecular imaging probes are expected to be developed in future. This review article will discuss the peptide homodimers and heterodimers for molecular imaging with special emphasis on peptide heterodimers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232091      PMCID: PMC3619030          DOI: 10.1007/s00726-010-0546-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  31 in total

1.  Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

Authors:  Xianzhong Zhang; Zhengming Xiong; Yun Wu; Weibo Cai; Jeffery R Tseng; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

2.  Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.

Authors:  Josef Vagner; Liping Xu; Heather L Handl; Jatinder S Josan; David L Morse; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

3.  microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

Authors:  Yun Wu; Xianzhong Zhang; Zhengming Xiong; Zhen Cheng; Darrell R Fisher; Shuang Liu; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

4.  A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

Authors:  A Shrivastava; M A von Wronski; A K Sato; D T Dransfield; D Sexton; N Bogdan; R Pillai; P Nanjappan; B Song; E Marinelli; D DeOliveira; C Luneau; M Devlin; A Muruganandam; A Abujoub; G Connelly; Q L Wu; G Conley; Q Chang; M F Tweedle; R C Ladner; R E Swenson; A D Nunn
Journal:  Protein Eng Des Sel       Date:  2005-08-08       Impact factor: 1.650

5.  (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Authors:  Zhaofei Liu; Yongjun Yan; Shuanglong Liu; Fan Wang; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

6.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Authors:  Yunpeng Ye; Sharon Bloch; Baogang Xu; Samuel Achilefu
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

Review 7.  Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

Authors:  Jean Claude Reubi; Beatrice Waser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-18       Impact factor: 9.236

Review 8.  Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Authors:  Shuang Liu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

9.  (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.

Authors:  Zi-Bo Li; Weibo Cai; Qizhen Cao; Kai Chen; Zhanhong Wu; Lina He; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

10.  18F-labeled BBN-RGD heterodimer for prostate cancer imaging.

Authors:  Zi-Bo Li; Zhanhong Wu; Kai Chen; Eun Kyoung Ryu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

View more
  15 in total

Review 1.  Dual-Targeted Molecular Imaging of Cancer.

Authors:  Emily B Ehlerding; Lingyi Sun; Xiaoli Lan; Dexing Zeng; Weibo Cai
Journal:  J Nucl Med       Date:  2018-01-04       Impact factor: 10.057

2.  In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.

Authors:  Arijit Ghosh; Natarajan Raju; Michael Tweedle; Krishan Kumar
Journal:  Cancer Biother Radiopharm       Date:  2017-02       Impact factor: 3.099

3.  Protein and peptide probes for molecular imaging.

Authors:  Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-11       Impact factor: 3.520

4.  Design and Investigation of a [18F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging.

Authors:  Dongzhi Yang; Anthony Comeau; Wayne D Bowen; Robert H Mach; Brian D Ross; Hao Hong; Marcian E Van Dort
Journal:  Mol Pharm       Date:  2017-02-14       Impact factor: 4.939

5.  A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.

Authors:  Yongjun Yan; Kai Chen; Min Yang; Xilin Sun; Shuanglong Liu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-10-10       Impact factor: 3.520

6.  Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe.

Authors:  Hua Wu; Haojun Chen; Dongfeng Pan; Yufei Ma; Sheng Liang; Ying Wan; Ya Fang
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

7.  Heterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cells.

Authors:  Ajay Shrivastava; Shu-Huei Wang; Natarajan Raju; Izabela Gierach; Haiming Ding; Michael F Tweedle
Journal:  Bioorg Med Chem Lett       Date:  2012-12-05       Impact factor: 2.823

8.  Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Authors:  Patrick Fournier; Véronique Dumulon-Perreault; Samia Ait-Mohand; Réjean Langlois; François Bénard; Roger Lecomte; Brigitte Guérin
Journal:  EJNMMI Res       Date:  2012-02-14       Impact factor: 3.138

9.  Photo-Click-Facilitated Screening Platform for the Development of Hetero-Bivalent Agents with High Potency.

Authors:  Lingyi Sun; Yongkang Gai; Christopher D McNitt; Jun Sun; Xiaohui Zhang; Wei Xing; Zhonghan Li; Vladimir V Popik; Dexing Zeng
Journal:  J Org Chem       Date:  2020-04-07       Impact factor: 4.354

10.  Multiplexed Targeting of Barrett's Neoplasia with a Heterobivalent Ligand: Imaging Study on Mouse Xenograft in Vivo and Human Specimens ex Vivo.

Authors:  Jing Chen; Juan Zhou; Zhenghong Gao; Xue Li; Fa Wang; Xiyu Duan; Gaoming Li; Bishnu P Joshi; Rork Kuick; Henry D Appelman; Thomas D Wang
Journal:  J Med Chem       Date:  2018-06-19       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.